Open AccessRapid Progression after Ibrutinib Discontinuation in a Mantle Cell Lymphoma Patient with Severe COVID-19 Infection
Author(s) -
Fehmi Hindilerden,
İpek Yönal Hindilerden,
Reyhan Diz Küçükkaya
Publication year - 2020
Publication title -
balkan medical journal/balkan medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.398
H-Index - 16
eISSN - 2146-3131
pISSN - 2146-3123
DOI - 10.4274/balkanmedj.galenos.2020.2020.9.106
Subject(s) - ibrutinib , mantle cell lymphoma , discontinuation , medicine , covid-19 , lymphoma , oncology , intensive care medicine , pathology , leukemia , chronic lymphocytic leukemia , disease , infectious disease (medical specialty) , outbreak